Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT

Münstermann, 1990, Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue, Eur. J. Biochem., 189, 251, 10.1111/j.1432-1033.1990.tb15484.x

Ahmed, 2000, Significance of protein kinase CK2 nuclear signaling in neoplasia, J. Cell. Biochem. Suppl., 35, 130, 10.1002/1097-4644(2000)79:35+<130::AID-JCB1136>3.0.CO;2-N

Landesman-Bollag, 2001, Protein kinase CK2 in mammary gland tumorigenesis, Oncogene, 20, 3247, 10.1038/sj.onc.1204411

Guerra, 1999, CK2: a protein kinase in need of control, Pharmacol. Ther., 82, 303, 10.1016/S0163-7258(98)00064-3

Lykkesfeldt, 1995, Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment, Int. J. Cancer, 61, 529, 10.1002/ijc.2910610417

Lykkesfeldt, 1986, Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines, Br. J. Cancer, 53, 29, 10.1038/bjc.1986.5

Lykkesfeldt, 1994, Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1, Cancer Res., 54, 1587

Naundorf, 1992, Establishment and characterization of a new human oestradiol- and progesterone-receptor-positive mammary carcinoma serially transplantable in nude mice, J. Cancer Res. Clin. Oncol., 119, 35, 10.1007/BF01209485

Naundorf, 2000, Development and characterization of a tamoxifen-resistant breast carcinoma xenograft, Br. J. Cancer, 82, 1844, 10.1054/bjoc.2000.1156

Garcia-Calvo, 1998, Inhibition of human caspases by peptide-based and macromolecular inhibitors, J. Biol. Chem., 273, 32608, 10.1074/jbc.273.49.32608

Lademann, 2003, Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex, Mol. Cell. Biol., 23, 7829, 10.1128/MCB.23.21.7829-7837.2003

Lundholt, 2001, Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways, Breast Cancer Res. Treat., 67, 199, 10.1023/A:1017977406429

Yde, 2006, Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1, Int. J. Oncol., 29, 1397

Zhu, 1996, Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types, EMBO J., 15, 4130, 10.1002/j.1460-2075.1996.tb00788.x

Kanda, 1998, Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells, Curr. Biol., 8, 377, 10.1016/S0960-9822(98)70156-3

Yde, 2007, Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death, Mol. Cancer Ther., 6, 1869, 10.1158/1535-7163.MCT-07-0072

Seldin, 2005, CK2 as a positive regulator of Wnt signalling and tumourigenesis, Mol. Cell. Biochem., 274, 63, 10.1007/s11010-005-3078-0

Zhang, 2001, Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res., 61, 8664

Tapia, 2006, Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription, Proc. Natl. Acad. Sci. USA, 103, 15079, 10.1073/pnas.0606845103

Arnold, 1994, Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor, Mol. Endocrinol., 8, 1208, 10.1210/me.8.9.1208

Lin, 1996, Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability, Mol. Cell. Biol., 16, 1401, 10.1128/MCB.16.4.1401

O’Brien, 1999, Casein kinase 2 binds to and phosphorylates BRCA1, Biochem. Biophys. Res. Commun., 260, 658, 10.1006/bbrc.1999.0892

Meek, 1990, The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II, EMBO J., 9, 3253, 10.1002/j.1460-2075.1990.tb07524.x

Hjerrild, 2001, Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells, Biochem. J., 355, 347, 10.1042/0264-6021:3550347

Torres, 2001, The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation, J. Biol. Chem., 276, 993, 10.1074/jbc.M009134200

Guerra, 2006, Protein kinase CK2 subunits are positive regulators of AKT kinase, Int. J. Oncol., 28, 685

Di Maira, 2005, Protein kinase CK2 phosphorylates and upregulates Akt/PKB, Cell Death Differ., 12, 668, 10.1038/sj.cdd.4401604

Frogne, 2005, Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth, Endocr. Relat. Cancer, 12, 599, 10.1677/erc.1.00946

Guerra, 1999, Protein kinase CK2 and its role in cellular proliferation, development and pathology, Electrophoresis, 20, 391, 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N

Ahmed, 2002, Joining the cell survival squad: an emerging role for protein kinase CK2, Trends Cell Biol., 12, 226, 10.1016/S0962-8924(02)02279-1

D. Behrens, A.E. Lykkesfeldt, I. Fichtner, The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts, Targeted Oncology. Available online 30 June 2007.

Slaton, 2004, Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model, Mol. Cancer Res., 2, 712, 10.1158/1541-7786.712.2.12

Seeber, 2005, Validation of protein kinase CK2 as oncological target, Apoptosis, 10, 875, 10.1007/s10495-005-0380-y

Izeradjene, 2004, Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells, Clin. Cancer Res., 10, 6650, 10.1158/1078-0432.CCR-04-0576

Yamane, 2005, CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation, Cancer Res., 65, 4362, 10.1158/0008-5472.CAN-04-3941